• search

Ranbaxy chief steps down, Japanese firm takes over

Written by: Staff

New Delhi, May 25: Ranbaxy Laboratories' managing director and chief executive, Malvinder Mohan has reportedly stepped down and Atul Sobti, the current chief operating officer, has been appointed as chief executive and managing director.

India's largest pharmaceuticals company was acquired by Japan's Daiichi Sankyo in 2008 and Tsutomu Une, the company's non-executive director, will now serve as its chairman.

"We very much appreciate the efforts of the Singh family, which grew Ranbaxy from a small, local Indian company to the large multi-national company it has become today," said Takashi Shoda, chief executive of Daiichi Sankyo.

Admitting that it was tough to 'separate from Ranbaxy' but said he was stepping down as the company's acquisition was complete.

OneIndia News

For Daily Alerts
Get Instant News Updates
Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Oneindia sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Oneindia website. However, you can change your cookie settings at any time. Learn more